This focused issue on “VATS in Lung Metastasectomy” is edited by Dr. Marcello Migliore, from Section of General Thoracic Surgery, University of Catania, Policlinic University Hospital, Catania, Italy; and Dr. Michel Gonzalez, from Service of Thoracic Surgery, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Switzerland.
This focused issue is designed to review current and future management techniques in the field of lung metastasectomy. All aspects of surgical management will be addressed in particular the VATS approach.
Marcello Migliore, MD, PhD, FETCS
Section of General Thoracic Surgery, University of Catania, Policlinic University Hospital, Catania, Italy
Dr. Marcello Migliore is currently Full Professor of thoracic surgery at University of Catania, and his research includes oncologic trials (lung metastases, mesothelioma, and HITHOC for mesothelioma and lung cancer), development of new technology and clinical strategies. He has been a pioneer in Uniportal VATS in 1998 and specialized in the surgical treatment of diseases of the lung, mediastinum, pleura and the esophagus. He is a member of the SCTS, ERS, ESTS and STS. He acts as a reviewer for several international prestigious thoracic journals. Dr. Migliore has been elected chairman for thoracic surgery of the European Respiratory Society (ERS) for the triennium 2019-2022. He has authored many papers in peer-reviewed journals and textbook chapters, authored a book manually in thoracic surgery, and has been invited Lecturer and Faculty member at several national and international conferences.
Michel Gonzalez, MD
Service of Thoracic Surgery, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Switzerland.
Dr. Michel Gonzalez is staff thoracic surgeon in the Service of Thoracic Surgery in Lausanne, Switzerland. He is also involved in the Lung Transplantation program. His research interests include lung and mediastinal surgery, minimal invasive thoracic surgery, enhanced recovery pathways and pulmonary metastasectomy. He recently participated to the establishment of the ERAS/ESTS guidelines. He is author or co-author of more than 80 scientific articles.
Focused issue outline:
The complete outline of this focused issue is listed below:
- Introduction to the focused issue
- Last 10 years of LM, Ongoing Trials and Future Directions
- What is New in Lung Metastasectomy: An Overview
- TNM Classification for Lung Metastasis
- What Did the PulMicc Trial Teach Us?
- Personalized Approach for VATS Lung Metastases
- Imaging Advancement in LM for the Thoracic Surgeon
- Is Preoperative Histological Diagnosis in LM Necessary?
- Algorithm for the Pulmonary Metastasectomy Based of Number of Metastases and Histology
- Uniportal VATS for LM Technique and Results
- Multiportal VATS for Lung Metastasectomy Technique and Results
- Robotic approach for Lung Metastasectomy Technique and Results
- What are the Indications for Open Lung Metastasectomy
- Wedge, Segmentectomy and Lobectomy for Lung Metastasectomy: When?
- Awake Surgery for Lung Metastasectomy
- Survival after VATS for Lung Metastasectomy
- VATS for Colorectal Lung Metastases: Indications and Results
- New Technology in Lung Metastasectomy
- The Use of Near-Infrared Intraoperative Imaging for VATS Metastasectomy
- 99mTechnetium and Methylene Blue Guided for Pre-Operative Pulmonary Metastasis Localization
- The Role of Lymph Node Dissection During VATS Lung Metastasectomy
- Subxyphoid VATS Pulmonary Metastasectomy
- VATS Segmentectomy for Pulmonary Metastases
- Extended VATS Pulmonary Metastasectomy